STAA News and Press, STAAR Surgical Company From 08/09/23

2023-08-09 02:36:04 ET Summary STAAR Surgical Company's Q2 FY'23 earnings missed consensus estimates. The key revenue driver for STAA is its Implantable Collamer Lenses, which saw a 21% YoY increase in unit volumes. Despite potential topline growth, the economic realities and ...

2023-08-03 19:18:59 ET Shares of STAAR Surgical (NASDAQ: STAA) were down 9.6% on Thursday, according to data provided by S&P Global Market Intelligence , after announcing mixed quarterly results relative to Wall Street's expectations and lowering its near-term outlook. T...

2023-08-03 15:01:12 ET Canaccord Genuity has downgraded STAAR Surgical ( NASDAQ: STAA ) to hold, citing slower-than-expected adoption of its surgically implanted EVO lenses in the US and economic headwinds in Europe and South Korea. Canaccord said that while demand in China for ...

2023-08-03 09:05:43 ET Aravive ( ARAV ) -58% announces top-line results from phase 3 AXLerate-OC study of batiraxcept in patinum-resistant ovarian cancer. Vicarious Surgical ( RBOT ) -41% on pricing $45M offering . DXC Technology Company ( DXC ) -24% ...

2023-08-02 23:06:02 ET STAAR Surgical Company (STAA) Q2 2023 Earnings Conference Call August 2, 2023 16:30 ET Company Participants Brian Moore - Investor Relations Tom Frinzi - President and Chief Executive Officer Patrick Williams - Chief Financial Officer ...

2023-08-02 17:56:07 ET Gainers: Upwork  ( UPWK ) +19% . Remitly Global ( RELY ) +17% . Pulmonx Corporation ( LUNG ) +13% . Confluent ( CFLT ) +11% . EVgo  ( EVGO ) +11% . Losers: Roivant Sciences  ( ROIVW...

2023-08-02 17:36:55 ET STAAR Surgical press release ( NASDAQ: STAA ): Q2 Non-GAAP EPS of $0.19 misses by $0.11 . Revenue of $92.3M (+13.8% Y/Y) misses by $0.23M . Cash, Cash Equivalents and Investments Available for Sale Ended the Quarter at $209.5 Million ...

Record ICL Sales of $93.1 Million Up 19% Y/Y STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Overview ...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release financial results for the second quarter ended June 30, 2023 on Wednesday, August 2, 2023 after the market close. STAAR...

2023-07-12 06:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy underperf...